Surface Oncology, Inc. Common Stock (SURF)

SURF was delisted on the 7th of September, 2023.

• Market cap: $65.1M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors in the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out throughout the region of the United States.

Employees: 35